January 1-4, 2026 | Location to be Determined
Scientific Organizers:
January 1-4, 2026 | Location to be Determined
Scientific Organizers:
Important Deadlines
Meeting Summary
The HIV vaccine field is at a critical juncture with immunological and virological discoveries from HIV infection having resulted in the generation of highly engineered vaccines, many now in advanced clinical trials in humans. These clinical insights are paired with detailed immunological analyses resulting in unparalleled depth of understanding of vaccine responses. Allied with ongoing studies of the natural history of HIV infection across diverse geographies, and innovations in protein engineering, adjuvant design and novel vaccine platforms, this intersection between clinical and basic sciences is accelerating the pace of HIV vaccines. This Keystone meeting, joint with an HIV Cure meeting, will bring together basic scientists and clinical trialists at a moment when experimental medicine trials will provide novel insights into HIV prevention and treatment.
SPECIAL RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR SPONSOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
KEYSTONE SYMPOSIA THANKS OUR MEETING EXHIBITOR(S):
KEYSTONE SYMPOSIA THANKS THESE DONOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
THESE COMPANIES HAVE GENEROUSLY AGREED TO COVER THE EXPENSES OF THEIR EMPLOYEES WHO ARE SPEAKING AT THIS MEETING:
GRANT RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS
Subscribe for Updates